公开(公告)号：US20050202076A1

公开(公告)日：2005-09-15

申请号：US11018574

申请日：2004-12-22

申请人： Carsten Mundus ,  Christain Welz ,  Oliver Schramel ,  Heinrich Haas ,  Thomas Fichert ,  Brita Schulze ,  Toralf Peymann ,  Uwe Michaelis ,  Michael Teifel ,  Friedrich Gruber ,  Gerhard Winter

发明人： Carsten Mundus ,  Christain Welz ,  Oliver Schramel ,  Heinrich Haas ,  Thomas Fichert ,  Brita Schulze ,  Toralf Peymann ,  Uwe Michaelis ,  Michael Teifel ,  Friedrich Gruber ,  Gerhard Winter

IPC分类号： A61K9/127 ,  A61K31/335 ,  A61K31/337 ,  A61K31/47 ,  A61K31/4745 ,  A61K47/24 ,  A61K47/28 ,  A61K47/48 ,  A61K49/18 ,  A61P35/00 ,  C07D471/14

CPC分类号： A61K31/337 ,  A61K9/127 ,  A61K9/1272 ,  A61K31/335 ,  A61K31/47 ,  A61K31/4745 ,  A61K47/34 ,  A61K47/543 ,  A61K47/56 ,  A61K47/6911 ,  A61K49/1812 ,  B82Y5/00 ,  C07D471/14

摘要： A method for producing a cationic liposomal preparation comprising a lipophilic active compound with physical and chemical stability during manufacturing, storing and reconstituting, and further a cationic liposomal preparation obtainable by this method as well as specific cationic liposomal preparations as well as pharmaceutical compositions are disclosed.

摘要翻译： 公开了一种阳离子脂质体制剂的制备方法，其包括在制造，储存和重构过程中具有物理和化学稳定性的亲脂性活性化合物，以及可通过该方法获得的阳离子脂质体制剂以及特定的阳离子脂质体制剂以及药物组合物。

公开(公告)号：US20110038926A1

公开(公告)日：2011-02-17

申请号：US12859000

申请日：2010-08-18

申请人： Carsten Mundus ,  Christain Welz ,  Oliver Schramel ,  Heinrich Haas ,  Thomas Fichert ,  Brita Schulze ,  Toralf Peymann ,  Uwe Michaelis ,  Michael Teifel ,  Friedrich Gruber ,  Gerhard Winter

发明人： Carsten Mundus ,  Christain Welz ,  Oliver Schramel ,  Heinrich Haas ,  Thomas Fichert ,  Brita Schulze ,  Toralf Peymann ,  Uwe Michaelis ,  Michael Teifel ,  Friedrich Gruber ,  Gerhard Winter

IPC分类号： A61K9/127 ,  A61K31/337 ,  A61P35/00

CPC分类号： A61K31/337 ,  A61K9/127 ,  A61K9/1272 ,  A61K31/335 ,  A61K31/47 ,  A61K31/4745 ,  A61K47/34 ,  A61K47/543 ,  A61K47/56 ,  A61K47/6911 ,  A61K49/1812 ,  B82Y5/00 ,  C07D471/14

摘要： A method for producing a cationic liposomal preparation comprising a lipophilic active compound with physical and chemical stability during manufacturing, storing and reconstituting, and further a cationic liposomal preparation obtainable by this method as well as specific cationic liposomal preparations as well as pharmaceutical compositions are disclosed.